Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Nakanishi ( (JP:7716) ).
Nakanishi reported consolidated net sales of ¥81.2 billion for fiscal 2025, up 5.4% year on year, while operating and ordinary income slipped 3.5% and 2.0% respectively. The company swung to a net loss attributable to owners of ¥2.4 billion, compared with a ¥8.6 billion profit a year earlier, as its equity ratio declined from 76.3% to 71.0% amid lower net assets.
Despite the loss, Nakanishi lifted its annual dividend for 2025 to ¥54 per share from ¥52 and is guiding a further increase to ¥60 in 2026, signaling confidence in its cash flow and balance sheet. For 2026, the company forecasts net sales to rise to ¥88.2 billion and operating income to ¥15.6 billion, with a recovery to ¥10.9 billion in profit attributable to owners, implying a sharp rebound in earnings per share and an ongoing commitment to shareholder returns.
The most recent analyst rating on (JP:7716) stock is a Hold with a Yen2222.00 price target. To see the full list of analyst forecasts on Nakanishi stock, see the JP:7716 Stock Forecast page.
More about Nakanishi
Nakanishi Inc. is a Japan-based manufacturer listed on the Tokyo Stock Exchange Standard Market, operating in the precision equipment and dental/medical device-related sector. The company focuses on high-speed rotary instruments and related products, serving professional healthcare and industrial markets globally and reporting its results under Japan GAAP on a consolidated basis.
Average Trading Volume: 190,531
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen190.9B
For a thorough assessment of 7716 stock, go to TipRanks’ Stock Analysis page.